UK lists Covishield as ‘approved’ vaccine in revised travel advisory
London: The United Kingdom revised its travel advisory on Wednesday in which it said that Covishield, the coronavirus disease vaccine jointly developed by AstraZeneca and Oxford University and manufactured by the Serum Institute of India (SII) – will qualify as an approved vaccine for travellers visiting Britain from any part of the world from October 4 onwards.
However, Indians vaccinated with both doses of Covishield will still need to quarantine in the UK due to an issue over ‘vaccine certification’, even though the country has been added to the ‘amber list’ according to the latest travel rules.